DE3684755D1 - Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung. - Google Patents

Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung.

Info

Publication number
DE3684755D1
DE3684755D1 DE8686307244T DE3684755T DE3684755D1 DE 3684755 D1 DE3684755 D1 DE 3684755D1 DE 8686307244 T DE8686307244 T DE 8686307244T DE 3684755 T DE3684755 T DE 3684755T DE 3684755 D1 DE3684755 D1 DE 3684755D1
Authority
DE
Germany
Prior art keywords
preparations
animals
treatment
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686307244T
Other languages
English (en)
Inventor
Jack Henry Nunberg
Arthur Debney Newell
Michael Varian Doyle
Thomas James White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/856,680 external-priority patent/US4818769A/en
Application filed by Cetus Corp filed Critical Cetus Corp
Application granted granted Critical
Publication of DE3684755D1 publication Critical patent/DE3684755D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55533—IL-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8686307244T 1985-09-20 1986-09-19 Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung. Expired - Lifetime DE3684755D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US77837185A 1985-09-20 1985-09-20
US77837085A 1985-09-20 1985-09-20
US77837285A 1985-09-20 1985-09-20
US85603586A 1986-04-25 1986-04-25
US06/856,680 US4818769A (en) 1985-09-20 1986-04-25 Method of controlling stress-related disease in livestock by administration of human IL-2

Publications (1)

Publication Number Publication Date
DE3684755D1 true DE3684755D1 (de) 1992-05-14

Family

ID=27542198

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686307244T Expired - Lifetime DE3684755D1 (de) 1985-09-20 1986-09-19 Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung.

Country Status (6)

Country Link
EP (2) EP0219979B1 (de)
JP (1) JP2680809B2 (de)
CN (1) CN86106369A (de)
AU (1) AU587065B2 (de)
CA (1) CA1297003C (de)
DE (1) DE3684755D1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689224A (en) * 1985-10-07 1987-08-25 Neogen Corporation Method for administering vaccines containing equine leukokines and compositions therefor
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
AU589731B2 (en) * 1985-11-27 1989-10-19 Genetics Institute, Llc Colony stimulating factor for the treatment of aids-type diseases
US4931544A (en) * 1986-09-04 1990-06-05 Cetus Corporation Succinylated interleukin-2 for pharmaceutical compositions
CA1292686C (en) * 1986-10-27 1991-12-03 Ze'ev Shaked Pharmaceutical compositions of recombinant interleukin-2 and formulation process
US5725861A (en) * 1987-04-15 1998-03-10 Effem Gmbh Products and processes for gastric cascade and gastrointestinal disorder treatment with same
DE3818054C2 (de) * 1988-05-27 1994-02-17 Biotest Pharma Gmbh Verwendung einer Kombination aus einem Antigen bzw. einer Vakzine und humanem Interleukin zur Behandlung der Non-Responsiveness gegenüber immunologischen Defektzuständen
JPH0236129A (ja) * 1988-07-22 1990-02-06 Ajinomoto Co Inc ワクチン効果増強剤
JP2849671B2 (ja) * 1988-11-18 1999-01-20 エッフェム ゲゼルシャフト・ミット・ベシュレンクテル・ハフトウング 動物又はヒトにおいて成長率及び／又は飼料又は食物の利用及び／又は抵抗性を増加させる製品及びその方法
US5104651A (en) * 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
US6565841B1 (en) * 1991-03-15 2003-05-20 Amgen, Inc. Pulmonary administration of granulocyte colony stimulating factor
US6027735A (en) * 1992-07-28 2000-02-22 Effem Gmbh Products and processes for gastric cascade and gastrointestinal disorder treatment with same
NZ334627A (en) * 1999-03-12 2002-07-26 Horticulture & Food Res Inst A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
AU2002233045B2 (en) * 2001-02-26 2007-07-05 The University Of Sydney Method of improving the growth performance of an animal
CA2439116A1 (en) * 2001-02-26 2002-09-06 The University Of Sydney Method of improving the growth performance of an animal
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
KR20070003934A (ko) * 2004-03-05 2007-01-05 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 치료제의 환자 내약성을 예측하기 위한 시험관 내 테스트시스템

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
US4490289A (en) * 1982-09-16 1984-12-25 Hoffmann-La Roche Inc. Homogeneous human interleukin 2
JPS59501786A (ja) * 1982-09-20 1984-10-25 エンド−フイン，インコ−ポレイテツド 免疫刺戟体
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
EP0154316B1 (de) * 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemisch modifizierte Lymphokine und Verfahren zu ihrer Herstellung
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
EP0211835B1 (de) * 1984-03-28 1990-01-03 Cetus Corporation Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2
US5077195A (en) * 1985-03-01 1991-12-31 Board Of Reagents, The University Of Texas System Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
AU580431B2 (en) * 1985-06-26 1989-01-12 Cetus Corp Solubilization of proteins for pharmaceutical compositions using polymer conjugation

Also Published As

Publication number Publication date
AU587065B2 (en) 1989-08-03
JP2680809B2 (ja) 1997-11-19
CA1297003C (en) 1992-03-10
EP0219979A3 (en) 1988-04-27
EP0219979A2 (de) 1987-04-29
AU6294386A (en) 1987-03-26
CN86106369A (zh) 1987-04-01
EP0400762A1 (de) 1990-12-05
EP0219979B1 (de) 1992-04-08
JPS62123129A (ja) 1987-06-04

Similar Documents

Publication Publication Date Title
DE3854013D1 (de) Verwendung von N,N-Dialkylhydroxylaminen und ihre Herstellung.
DE3687646D1 (de) Biosensor und dessen herstellung.
DE3684948D1 (de) Imidderivate, ihre herstellung und anwendung.
DE3674906D1 (de) Selbstklemmende medizinische prothese und ihre herstellung.
DE3688296D1 (de) Arzneimittel zur behandlung von erbrechen.
FI874671A0 (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
DE3684755D1 (de) Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung.
DE3769122D1 (de) Nitro-derivate von 2-iminoimidazolidinen und 2-iminotetrahydropyrimidinen.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE3771146D1 (de) Pyrimidinderivate, ihre herstellung und medikamente, die diese derivate enthalten.
DE3777861D1 (de) Behandlung von gasen.
DE3670310D1 (de) Elektrochemische behandlung von ligninen.
DE3770184D1 (de) Behandlung von gasstroemen.
DE3789316D1 (de) Herstellung von human-parathyroidhormon.
DE3773722D1 (de) Inosose-derivate und ihre herstellung.
DE3670956D1 (de) Behandlung von fluessigkeiten.
DE3581210D1 (de) Immunotoxin und herstellung.
DE3680881D1 (de) Behandlung von hologrammen.
DE3682882D1 (de) Menschliches immunoglobulin-g-fc-region-protein und dessen herstellung.
DE3586952D1 (de) Fibrinophiler urokinase-komplex und dessen herstellung.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
DE3689036D1 (de) Lankacidinderivate und ihre Herstellung.
ATE74511T1 (de) Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung.
DE3675720D1 (de) Behandlung von material aus lignocellulose.
DE3672892D1 (de) Herstellung von s-aryl-s-alkyl-dithiocarbonaten, arylthiolen und arylthioethern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CHIRON CORP. (N.D.GES.D. STAATES DELAWARE), EMERYV

8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US